Show simple item record

dc.contributor.authorDomingo-Relloso, Arce 
dc.contributor.authorRiffo-Campos, Angela L
dc.contributor.authorPowers, Martha
dc.contributor.authorTellez-Plaza, Maria 
dc.contributor.authorHaack, Karin
dc.contributor.authorBrown, Robert H
dc.contributor.authorUmans, Jason G
dc.contributor.authorFallin, M Daniele
dc.contributor.authorCole, Shelley A
dc.contributor.authorNavas-Acien, Ana
dc.contributor.authorSanchez, Tiffany R
dc.date.accessioned2023-04-14T10:50:54Z
dc.date.available2023-04-14T10:50:54Z
dc.date.issued2022-06-09
dc.identifier.citationClin Epigenetics. 2022 Jun 9;14(1):75.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15809
dc.description.abstractBackground: Epigenetic modifications, including DNA methylation (DNAm), are often related to environmental exposures, and are increasingly recognized as key processes in the pathogenesis of chronic lung disease. American Indian communities have a high burden of lung disease compared to the national average. The objective of this study was to investigate the association of DNAm and lung function in the Strong Heart Study (SHS). We conducted a cross-sectional study of American Indian adults, 45-74 years of age who participated in the SHS. DNAm was measured using the Illumina Infinium Human MethylationEPIC platform at baseline (1989-1991). Lung function was measured via spirometry, including forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC), at visit 2 (1993-1995). Airflow limitation was defined as FEV1 < 70% predicted and FEV1/FVC < 0.7, restriction was defined as FEV1/FVC > 0.7 and FVC < 80% predicted, and normal spirometry was defined as FEV1/FVC > 0.7, FEV1 > 70% predicted, FVC > 80% predicted. We used elastic-net models to select relevant CpGs for lung function and spirometry-defined lung disease. We also conducted bioinformatic analyses to evaluate the biological plausibility of the findings. Results: Among 1677 participants, 21.2% had spirometry-defined airflow limitation and 13.6% had spirometry-defined restrictive pattern lung function. Elastic-net models selected 1118 Differentially Methylated Positions (DMPs) as predictors of airflow limitation and 1385 for restrictive pattern lung function. A total of 12 DMPs overlapped between airflow limitation and restrictive pattern. EGFR, MAPK1 and PRPF8 genes were the most connected nodes in the protein-protein interaction network. Many of the DMPs targeted genes with biological roles related to lung function such as protein kinases. Conclusion: We found multiple differentially methylated CpG sites associated with chronic lung disease. These signals could contribute to better understand molecular mechanisms involved in lung disease, as assessed systemically, as well as to identify patterns that could be useful for diagnostic purposes. Further experimental and longitudinal studies are needed to assess whether DNA methylation has a causal role in lung disease.es_ES
dc.description.sponsorshipThis work was supported by Grants from the National Heart, Lung, and Blood Institute (NHLBI) (Contract Numbers 75N92019D00027, 75N92019D00028, 75N92019D00029 and 75N92019D00030) and previous Grants (R01HL090863, R01HL109315, R01HL109301, R01HL109284, R01HL109282, and R01HL109319 and cooperative agreements: U01HL41642, U01HL41652, U01HL41654, U01HL65520 and U01HL65521); by the National Institute of Environmental Health Sciences (Grant Numbers R01ES021367, R01ES025216, P42ES033719, P30ES009089), by ANID—Millennium Science Initiative Program—No NCS2021_013—SocioMed (ALRC), by the Maria Zambrano grant Nº ZA21-063 for the requalification of the Spanish university system—NextGeneration EU (ALRC) and by a fellowship from “la Caixa” Foundation (ID 100010434) (fellowship code “LCF/BQ/DR19/11740016”) (ADR). The funders had no role in the planning, conducting, analysis, interpretation, or writing of this study. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (United States) or the National Health Institute Carlos III (Spain).es_ES
dc.language.isoenges_ES
dc.publisherBioMed Central (BMC) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectDNA methylationes_ES
dc.subjectLung functiones_ES
dc.subjectLung diseasees_ES
dc.subjectEpigeneticses_ES
dc.subjectAmerican Indianses_ES
dc.subject.meshEpigenome es_ES
dc.subject.meshLung Diseases es_ES
dc.subject.meshAdult es_ES
dc.subject.meshCross-Sectional Studies es_ES
dc.subject.meshDNA Methylation es_ES
dc.subject.meshHumans es_ES
dc.subject.meshLung es_ES
dc.subject.meshAmerican Indian or Alaska Nativees_ES
dc.titleAn epigenome-wide study of DNA methylation profiles and lung function among American Indians in the Strong Heart Studyes_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID35681244es_ES
dc.format.volume14es_ES
dc.format.number1es_ES
dc.format.page75es_ES
dc.identifier.doi10.1186/s13148-022-01294-8es_ES
dc.contributor.funderNIH - National Heart, Lung, and Blood Institute (NHLBI) (Estados Unidos) es_ES
dc.contributor.funderNIH - National Institute of Environmental Health Sciences (NIEHS) (Estados Unidos) es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1868-7083es_ES
dc.relation.publisherversionhttps://doi.org/10.1186/s13148-022-01294-8es_ES
dc.identifier.journalClinical epigeneticses_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This item is licensed under a: Atribución 4.0 Internacional